Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10005458HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10009798HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018472HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10005008HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10019805HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10005007HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10006916HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10006930HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10006926HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10006982HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807